M. Nissilä
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies 19
- Spondyloarthritis Studies and Treatments 8
- Systemic Lupus Erythematosus Research 5
- Psychiatry and Mental health top 5%
- Migraine and Headache Studies 9
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 4
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 9
-
- Influenza Virus Research Studies 5
-
- Peripheral Neuropathies and Disorders 4
- Co-authors
- H IsomäkiMarjatta Leirisalo‐RepoK. LehtinenJ. MartioAarno PalotieKaisa GranforsReijo LuukkainenU. I. Yli-Kerttula
- Partner nations
- FinlandUnited StatesFrance
In The Last Decade
M. Nissilä
48 papers receiving 827 citations
Peers
Comparison fields: 5 of 84
- Rheumatology 448
- Psychiatry and Mental health 224
- Hematology 99
- Medical Terminology 2
- Pharmacology 115
Countries citing papers authored by M. Nissilä
This map shows the geographic impact of M. Nissilä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Nissilä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Nissilä more than expected).
Fields of papers citing papers by M. Nissilä
This network shows the impact of papers produced by M. Nissilä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Nissilä. The network helps show where M. Nissilä may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Nissilä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 15 | |
| 8 | 2019 | 31 | |
| 9 | 2006 | 18 | |
| 10 | 2004 | 17 | |
| 11 | Efficacy and safety of meloxicam in patients with rheumatoid arthritis. | 1997 | 35 |
| 12 | 1995 | 15 | |
| 13 | 1990 | 21 | |
| 14 | 1990 | 21 | |
| 15 | 1988 | 93 | |
| 16 | 1988 | 2 | |
| 17 | 1988 | 5 | |
| 18 | 1983 | 6 | |
| 19 | 1977 | 8 | |
| 20 | 1977 | 19 |
About M. Nissilä
M. Nissilä is a scholar working on Rheumatology, Pharmacology and Psychiatry and Mental health, having authored 50 papers that have together received 899 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (19 papers), Migraine and Headache Studies (9 papers), Inflammatory mediators and NSAID effects (9 papers), Spondyloarthritis Studies and Treatments (8 papers), Influenza Virus Research Studies (5 papers), Systemic Lupus Erythematosus Research (5 papers), Peripheral Neuropathies and Disorders (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). The work is most often cited by research in Rheumatology (448 citations), Psychiatry and Mental health (224 citations) and Hematology (99 citations). M. Nissilä has collaborated with scholars based in Finland, United States and France. Frequent co-authors include H Isomäki, Marjatta Leirisalo‐Repo, K. Lehtinen, J. Martio, Aarno Palotie, Kaisa Granfors, Reijo Luukkainen, U. I. Yli-Kerttula, Maija Wessman and Mikko Kallela. Their work appears in journals such as New England Journal of Medicine, The Lancet and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.